Concepedia

Richard Létourneau

RL

Statistics

Publications

14

Citations

1.2K

H-Index

12

Active since

2000

Affiliations

Centre Hospitalier de l’Université de Montréal(Current)

Hôpital Saint-Luc

Université de Montréal

University of Antwerp

Moffitt Cancer Center

Richard Létourneau is an author at Centre Hospitalier de l’Université de Montréal specializing in medicine, oncology, and surgery.

Publications per year

2000–2022

14

Publications

14

Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study

Hedy L. Kindler, Tatsuya Ioka, D. J. Richel et al. · The Lancet Oncology · 2011 · 396 citations

, , +7

Randomized Phase III Study of Exatecan and Gemcitabine Compared With Gemcitabine Alone in Untreated Advanced Pancreatic Cancer

Ghassan K. Abou‐Alfa, Richard Létourneau, Graydon Harker et al. · Journal of Clinical Oncology · 2006 · 278 citations · Full text

, , +15

Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study

Jean‐Philippe Spano, Catherine Chodkiewicz, Joan Maurel et al. · The Lancet · 2008 · 249 citations

, , +8

Transjugular Intrahepatic Portosystemic Shunt before Abdominal Surgery in Cirrhotic Patients: A Retrospective, Comparative Study

Évelyne Vinet, Pierre Perreault, Louis‐S. Bouchard et al. · Canadian Journal of Gastroenterology · 2006 · 73 citations · Full text

, , +16

Prognostic value of CD73 expression in resected colorectal cancer liver metastasis

Nouredin Messaoudi, Isabelle Cousineau, Elizabeth Arslanian et al. · OncoImmunology · 2020 · 49 citations · Full text

, , +17

1–5 of 14